Technology
Health
Pharmaceutical

ANI Pharmaceuticals

$66.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.67 (1.02%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell ANIP and other stocks, options, ETFs, and crypto commission-free!

About

ANI Pharmaceuticals, Inc., also called ANI Pharmaceuticals, is a pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. Read More The company was founded on August 29, 1996 and is headquartered in Baudette, MN.

Employees
299
Headquarters
Baudette, Minnesota
Founded
1996
Market Cap
790.50M
Price-Earnings Ratio
51.28
Dividend Yield
0.00
Average Volume
81.64K
High Today
$66.81
Low Today
$65.42
Open Price
$65.97
Volume
27.22K
52 Week High
$72.81
52 Week Low
$36.92

Collections

Technology
Health
Pharmaceutical
Manufacturing
Advertising and Marketing
Business Services
2013 IPO
US

News

TradingNewsNowMar 21

Present Change: ANI Pharmaceuticals (NASDAQ: ANIP)

ANI Pharmaceuticals trades as part of the biotechnology industry and healthcare sector. The company CEO is Arthur S. Przybyl. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Previous Intraday Trading Performance: The ANIP stock showed a previous change of 1.80% with an open at 63.20 and a close of 64.45. It reached an intraday high of 65.94 and a...

2
TradingNewsNowMar 6

Latest Fundamentals: ANI Pharmaceuticals (NASDAQ: ANIP)

ANI Pharmaceuticals trades as part of the biotechnology industry and is part of the healthcare sector. The company CEO is Arthur S. Przybyl. ANI Pharmaceuticals Inc is a specialty pharmaceutical company. The Company, together with its subsidiary is engaged in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Previous Intraday Trading Performance: The ANIP stock showed a previous change of -1.67% with an open at 64.77 and a close of 64.04. It reached an intraday hig...

5
Simply Wall StFeb 28

Is ANI Pharmaceuticals, Inc.’s (NASDAQ:ANIP) CEO Pay Fair?

In 2013 Arthur Przybyl was appointed CEO of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP). This report will, first, examine the CEO compensation levels in comparison to CEO compensation at companies of similar size. After that, we will consider the growth in the business. And finally – as a second measure of performance – we will look at the returns shareholders have received over the last few years. This method should give us information to assess how appropriately the company pays the CEO. Check out our latest...

10

Earnings

$0.87
$1.03
$1.18
$1.34
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 7, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.